FDA Approved: NATROBA — Supplemental Application (Cipher Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for NATROBA (spinosad) filed by Cipher Pharmaceuticals Inc., updating the labeling for the existing pediculicide.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head Lice Infestation
• Pediculosis Capitis

Drugs mentioned

• NATROBA (spinosad)

Snippet

SUPPL AP for NATROBA (SPINOSAD)